Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Immunologic Deficiency Syndromes 3Hematologic Neoplasms 3Thalassemia 2Myelodysplastic Syndromes 2Hemoglobinopathies 2Fanconi Anemia 2Anemia, Sickle Cell 2Multiple Myeloma 1Metabolic Diseases 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Anemia, Aplastic 1

Interventions

fludarabine 2fludarabine phosphate 1Thiotepa 1Melphalan 1Glucose Tolerance Test 1Continuous Glucose Monitoring 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Hemoglobinopathies × fludarabine × Clear all
NCT01316549 2021-10-04

HCT

University of California, San Francisco

Completed
67 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT03609814 2021-10-04

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

University of California, San Francisco

Completed
30 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡